The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Medical Molecular Imaging-Global Market Insights and Sales Trends 2024
Synopsis
The global Medical Molecular Imaging market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Medical Molecular Imaging in various end use industries. The expanding demands from the Oncology, Cardio and Vascular, Neurology and Others, are propelling Medical Molecular Imaging market. MRI, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CT segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Medical Molecular Imaging market, driven by demand from China, the second largest economy with some signs of stabilising, the Medical Molecular Imaging market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Medical Molecular Imaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Medical Molecular Imaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Medical Molecular Imaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Medical Molecular Imaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Medical Molecular Imaging covered in this report include Cardiarc, Digirad, Gamma Medica, GE, Gvi Medical Devices, Hitachi, Mediso, CMR Naviscan and Neurologica, etc.
The global Medical Molecular Imaging market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cardiarc
Digirad
Gamma Medica
GE
Gvi Medical Devices
Hitachi
Mediso
CMR Naviscan
Neurologica
Neusoft
BC Technical
Philips
Positron
Siemens
Biosensors International
Toshiba
Trivitron Healthcare
Molecular Devices
Global Medical Molecular Imaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Medical Molecular Imaging market, Segment by Type:
MRI
CT
PET
SPECT
Ultrasound
Global Medical Molecular Imaging market, by Application
Oncology
Cardio and Vascular
Neurology
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Medical Molecular Imaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Medical Molecular Imaging market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Medical Molecular Imaging in various end use industries. The expanding demands from the Oncology, Cardio and Vascular, Neurology and Others, are propelling Medical Molecular Imaging market. MRI, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CT segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Medical Molecular Imaging market, driven by demand from China, the second largest economy with some signs of stabilising, the Medical Molecular Imaging market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Medical Molecular Imaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Medical Molecular Imaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Medical Molecular Imaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Medical Molecular Imaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Medical Molecular Imaging covered in this report include Cardiarc, Digirad, Gamma Medica, GE, Gvi Medical Devices, Hitachi, Mediso, CMR Naviscan and Neurologica, etc.
The global Medical Molecular Imaging market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cardiarc
Digirad
Gamma Medica
GE
Gvi Medical Devices
Hitachi
Mediso
CMR Naviscan
Neurologica
Neusoft
BC Technical
Philips
Positron
Siemens
Biosensors International
Toshiba
Trivitron Healthcare
Molecular Devices
Global Medical Molecular Imaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Medical Molecular Imaging market, Segment by Type:
MRI
CT
PET
SPECT
Ultrasound
Global Medical Molecular Imaging market, by Application
Oncology
Cardio and Vascular
Neurology
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Medical Molecular Imaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Medical Molecular Imaging
1.1 Medical Molecular Imaging Market Overview
1.1.1 Medical Molecular Imaging Product Scope
1.1.2 Medical Molecular Imaging Market Status and Outlook
1.2 Global Medical Molecular Imaging Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Medical Molecular Imaging Market Size by Region (2018-2029)
1.4 Global Medical Molecular Imaging Historic Market Size by Region (2018-2023)
1.5 Global Medical Molecular Imaging Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Medical Molecular Imaging Market Size (2018-2029)
1.6.1 North America Medical Molecular Imaging Market Size (2018-2029)
1.6.2 Europe Medical Molecular Imaging Market Size (2018-2029)
1.6.3 Asia-Pacific Medical Molecular Imaging Market Size (2018-2029)
1.6.4 Latin America Medical Molecular Imaging Market Size (2018-2029)
1.6.5 Middle East & Africa Medical Molecular Imaging Market Size (2018-2029)
2 Medical Molecular Imaging Market by Type
2.1 Introduction
2.1.1 MRI
2.1.2 CT
2.1.3 PET
2.1.4 SPECT
2.1.5 Ultrasound
2.2 Global Medical Molecular Imaging Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Medical Molecular Imaging Historic Market Size by Type (2018-2023)
2.2.2 Global Medical Molecular Imaging Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Medical Molecular Imaging Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Medical Molecular Imaging Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Medical Molecular Imaging Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Medical Molecular Imaging Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Medical Molecular Imaging Revenue Breakdown by Type (2018-2029)
3 Medical Molecular Imaging Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Cardio and Vascular
3.1.3 Neurology
3.1.4 Others
3.2 Global Medical Molecular Imaging Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Medical Molecular Imaging Historic Market Size by Application (2018-2023)
3.2.2 Global Medical Molecular Imaging Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Medical Molecular Imaging Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Medical Molecular Imaging Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Medical Molecular Imaging Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Medical Molecular Imaging Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Medical Molecular Imaging Revenue Breakdown by Application (2018-2029)
4 Medical Molecular Imaging Competition Analysis by Players
4.1 Global Medical Molecular Imaging Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Medical Molecular Imaging as of 2022)
4.3 Date of Key Players Enter into Medical Molecular Imaging Market
4.4 Global Top Players Medical Molecular Imaging Headquarters and Area Served
4.5 Key Players Medical Molecular Imaging Product Solution and Service
4.6 Competitive Status
4.6.1 Medical Molecular Imaging Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cardiarc
5.1.1 Cardiarc Profile
5.1.2 Cardiarc Main Business
5.1.3 Cardiarc Medical Molecular Imaging Products, Services and Solutions
5.1.4 Cardiarc Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.1.5 Cardiarc Recent Developments
5.2 Digirad
5.2.1 Digirad Profile
5.2.2 Digirad Main Business
5.2.3 Digirad Medical Molecular Imaging Products, Services and Solutions
5.2.4 Digirad Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.2.5 Digirad Recent Developments
5.3 Gamma Medica
5.3.1 Gamma Medica Profile
5.3.2 Gamma Medica Main Business
5.3.3 Gamma Medica Medical Molecular Imaging Products, Services and Solutions
5.3.4 Gamma Medica Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.3.5 GE Recent Developments
5.4 GE
5.4.1 GE Profile
5.4.2 GE Main Business
5.4.3 GE Medical Molecular Imaging Products, Services and Solutions
5.4.4 GE Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.4.5 GE Recent Developments
5.5 Gvi Medical Devices
5.5.1 Gvi Medical Devices Profile
5.5.2 Gvi Medical Devices Main Business
5.5.3 Gvi Medical Devices Medical Molecular Imaging Products, Services and Solutions
5.5.4 Gvi Medical Devices Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.5.5 Gvi Medical Devices Recent Developments
5.6 Hitachi
5.6.1 Hitachi Profile
5.6.2 Hitachi Main Business
5.6.3 Hitachi Medical Molecular Imaging Products, Services and Solutions
5.6.4 Hitachi Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.6.5 Hitachi Recent Developments
5.7 Mediso
5.7.1 Mediso Profile
5.7.2 Mediso Main Business
5.7.3 Mediso Medical Molecular Imaging Products, Services and Solutions
5.7.4 Mediso Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.7.5 Mediso Recent Developments
5.8 CMR Naviscan
5.8.1 CMR Naviscan Profile
5.8.2 CMR Naviscan Main Business
5.8.3 CMR Naviscan Medical Molecular Imaging Products, Services and Solutions
5.8.4 CMR Naviscan Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.8.5 CMR Naviscan Recent Developments
5.9 Neurologica
5.9.1 Neurologica Profile
5.9.2 Neurologica Main Business
5.9.3 Neurologica Medical Molecular Imaging Products, Services and Solutions
5.9.4 Neurologica Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.9.5 Neurologica Recent Developments
5.10 Neusoft
5.10.1 Neusoft Profile
5.10.2 Neusoft Main Business
5.10.3 Neusoft Medical Molecular Imaging Products, Services and Solutions
5.10.4 Neusoft Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.10.5 Neusoft Recent Developments
5.11 BC Technical
5.11.1 BC Technical Profile
5.11.2 BC Technical Main Business
5.11.3 BC Technical Medical Molecular Imaging Products, Services and Solutions
5.11.4 BC Technical Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.11.5 BC Technical Recent Developments
5.12 Philips
5.12.1 Philips Profile
5.12.2 Philips Main Business
5.12.3 Philips Medical Molecular Imaging Products, Services and Solutions
5.12.4 Philips Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.12.5 Philips Recent Developments
5.13 Positron
5.13.1 Positron Profile
5.13.2 Positron Main Business
5.13.3 Positron Medical Molecular Imaging Products, Services and Solutions
5.13.4 Positron Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.13.5 Positron Recent Developments
5.14 Siemens
5.14.1 Siemens Profile
5.14.2 Siemens Main Business
5.14.3 Siemens Medical Molecular Imaging Products, Services and Solutions
5.14.4 Siemens Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.14.5 Siemens Recent Developments
5.15 Biosensors International
5.15.1 Biosensors International Profile
5.15.2 Biosensors International Main Business
5.15.3 Biosensors International Medical Molecular Imaging Products, Services and Solutions
5.15.4 Biosensors International Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.15.5 Biosensors International Recent Developments
5.16 Toshiba
5.16.1 Toshiba Profile
5.16.2 Toshiba Main Business
5.16.3 Toshiba Medical Molecular Imaging Products, Services and Solutions
5.16.4 Toshiba Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.16.5 Toshiba Recent Developments
5.17 Trivitron Healthcare
5.17.1 Trivitron Healthcare Profile
5.17.2 Trivitron Healthcare Main Business
5.17.3 Trivitron Healthcare Medical Molecular Imaging Products, Services and Solutions
5.17.4 Trivitron Healthcare Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.17.5 Trivitron Healthcare Recent Developments
5.18 Molecular Devices
5.18.1 Molecular Devices Profile
5.18.2 Molecular Devices Main Business
5.18.3 Molecular Devices Medical Molecular Imaging Products, Services and Solutions
5.18.4 Molecular Devices Medical Molecular Imaging Revenue (US$ Million) & (2018-2023)
5.18.5 Molecular Devices Recent Developments
6 North America
6.1 North America Medical Molecular Imaging Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Medical Molecular Imaging Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Medical Molecular Imaging Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Medical Molecular Imaging Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Medical Molecular Imaging Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Medical Molecular Imaging Market Dynamics
11.1 Medical Molecular Imaging Industry Trends
11.2 Medical Molecular Imaging Market Drivers
11.3 Medical Molecular Imaging Market Challenges
11.4 Medical Molecular Imaging Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
